Science
Mechanism of Action
The oil functions through a dual-action pathway: it inhibits the production of Nitric Oxide (NO) and inflammatory cytokines by modulating the p38/NF-κB signaling pathway. Simultaneously, it exerts antimicrobial pressure by disrupting the cytoplasmic membranes of pathogens and preventing the morphological transition of fungi, such as Candida albicans, from yeast to filamentous forms.
Research
Clinical Evidence
Medium confidence0.1%
Key findings
- 01 Demonstrated 90% inhibition of Candida albicans filamentation at a concentration of just 0.016%.
- 02 Significant reduction in Nitric Oxide production within macrophages achieved at 0.125% without compromising cell viability.
- 03 Local application of 1.0% Artemisia-derived oil showed clinical improvement in acne and eczema symptoms over a 14-day period.
Transparency
Dusting Analysis
Because this oil is effective at very low concentrations (0.016% for antifungal activity) but carries a low safety ceiling (0.1%), many formulations include it at trace 'label-only' levels that fall below the threshold for physiological anti-inflammatory impact.
The Formula
Formulation
Stability
Highly susceptible to oxidative degradation and alkaline environments; must be stored in light-protected, airtight vessels to maintain terpenoid integrity.
Synergies
- Salicylic Acid
- Low-pH surfactants
- Tocopherol
Conflicts
- Strong oxidizing agents
- High pH formulations (>7.0)
Safety
Safety Profile
Contains Thujone, a known neurotoxin at high levels; leave-on cosmetic use is strictly limited to low concentrations to mitigate systemic exposure and skin sensitization (GHS H317).
Your Skin
Skin Compatibility
Our Assessment
Verdict
An efficacious active for inflammatory and microbial skin concerns, provided it is formulated within the strict 0.016%–0.1% safety window.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources